DGX vs GL · P/E 22, rev $5.94B vs P/E 10, rev $3.16B
Quest Diagnostics Incorporated (DGX) versus Globe Life Inc (GL) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Globe Life Inc (GL) is a insurance - life company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported GL revenue for 2026-06-30 was $3.16B. Net income was $558.3M. GL currently screens at market cap $10.26B and trailing P/E 10.1.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. GL currently screens at market cap $10.26B and trailing P/E 10.1.
Not investment advice. Open the DGX and GL stock pages for the full models.
Not investment advice.